Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2022 Filed Jun 3, 2022 20:58 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantEmployee Stock Options (right to buy) · Derivative | 6,404 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034157 · doc4.xml · derivative · entry 3 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,404 Underlying: Ordinary Shares · 6,404 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,601 on June 2, 2023, 1,601 on June 3, 2024, 1,601 on June 2, 2025 and 1,601 on June 2, 2026 Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:58 UTC |
Madsen JuliaSenior VP, Life Sciences
|
GrantOrdinary Shares | 1,408 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034157 · doc4.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,606 F2 · shares: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. F2 · balance_after: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:56 UTC |
Fraser Mary ClareSVP & Chief HRO
|
GrantEmployee Stock Option (right to buy) · Derivative | 9,224 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034149 · doc4.xml · derivative · entry 3 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,224 Underlying: Ordinary Shares · 9,224 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,306 on June 2, 2023, 2,306 on June 3, 2024, 2,306 on June 2, 2025 and 2,306 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:56 UTC |
Fraser Mary ClareSVP & Chief HRO
|
GrantOrdinary Shares | 2,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034149 · doc4.xml · nonDerivative · entry 2 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,251 F2 · shares: As of June 2, 2022, 6,138 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025; 692 on October 1, 2025 and 2,028 on June 2, 2026. F2 · balance_after: As of June 2, 2022, 6,138 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025; 692 on October 1, 2025 and 2,028 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:03 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,748 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034191 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,748 Underlying: Ordinary Shares · 30,748 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 7,687 on June 2, 2023, 7,687 on June 3, 2024, 7,687 on June 2, 2025 and 7,687 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:03 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 2,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034191 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,415 F1 · shares: As of June 2, 2022, 10,356 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025 and 564 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 10,356 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 1,128 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025; 564 on June 2, 2025; 144 on October 1, 2025 and 564 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:01 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 79,948 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034183 · doc4.xml · derivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,948 Underlying: Ordinary Shares · 79,948 shares Expires 2032-06-02 F2 · derivative.exercise_date: This option becomes exercisable as follows: 19,987 on June 2, 2023, 19,987 on June 3, 2024, 19,987 on June 2, 2025 and 19,987 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:01 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantOrdinary Shares | 9,476 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034183 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,515 F1 · shares: As of June 2, 2022, 27,876 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025 and 2,369 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 27,876 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 2,369 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 2,369 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025; 2,369 on June 2, 2025; 289 on October 1, 2025 and 2,369 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:02 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,560 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034188 · doc4.xml · derivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,560 Underlying: Ordinary Shares · 2,560 shares Expires 2032-06-02 F2 · derivative.exercise_date: This option becomes exercisable as follows: 640 on June 2, 2023, 640 on June 3, 2024, 640 on June 2, 2025 and 640 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 21:02 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 564 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034188 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,129 F1 · shares: As of June 2, 2022, 2,624 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 556 on May 31, 2023; 584 on June 3, 2024; 282 on June 3, 2024; 432 on June 3, 2024; 258 on October 1, 2024; 144 on June 2, 2025; 141 on June 2, 2025; 86 on October 1, 2025 and 141 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 2,624 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 556 on May 31, 2023; 584 on June 3, 2024; 282 on June 3, 2024; 432 on June 3, 2024; 258 on October 1, 2024; 144 on June 2, 2025; 141 on June 2, 2025; 86 on October 1, 2025 and 141 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:59 UTC |
Majors Cary LSr VP Americas Com Operations
|
GrantEmployee Stock Option (right to buy) · Derivative | 9,736 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034162 · doc4.xml · derivative · entry 2 Majors Cary L · CIK 0001776271 · Sr VP Americas Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,736 Underlying: Ordinary Shares · 9,736 shares Expires 2032-06-02 F2 · derivative.exercise_date: This option becomes exercisable as follows: 2,434 on June 2, 2023; 2,434 on June 3, 2024; 2,434 on June 2, 2025 and 2,434 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:59 UTC |
Majors Cary LSr VP Americas Com Operations
|
GrantOrdinary Shares | 2,140 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034162 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP Americas Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,095 F1 · shares: As of June 2, 2022, 9,387 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025 and 2,140 on June 2, 2026. F1 · balance_after: As of June 2, 2022, 9,387 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025; 692 on October 1, 2025 and 2,140 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:57 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantEmployee Stock Option (right to buy) · Derivative | 15,372 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034152 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,372 Underlying: Ordinary Shares · 15,372 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,843 on June 2, 2023, 3,843 on June 3, 2024, 3,843 on June 2, 2025 and 3,843 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:57 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
GrantOrdinary Shares | 3,384 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034152 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,963 F2 · shares: As of June 2, 2022, 9,806 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. F2 · balance_after: As of June 2, 2022, 9,806 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:55 UTC |
Burton Karen LVP, Controller & CAO
|
GrantEmployee Stock option · Derivative | 4,100 | $0.00 Strike: $250.06 | $0.00 |
DisclosureSEC source: 0001209191-22-034143 · doc4.xml · derivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 Underlying: Ordinary Shares · 4,100 shares Expires 2032-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,025 on June 2, 2023, 1,025 on June 3, 2024, 1,025 on June 2, 2025 and 1,025 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 3, 2022 20:55 UTC |
Burton Karen LVP, Controller & CAO
|
GrantOrdinary Shares | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034143 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,155 F2 · shares: As of June 2, 2022, 2,679 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 196 on June 2, 2022; 86 on October 3, 2022; 255 on May 31, 2023; 198 on June 1, 2023; 225 on June 2, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025 and 225 on June 2, 2026. F2 · balance_after: As of June 2, 2022, 2,679 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 196 on June 2, 2022; 86 on October 3, 2022; 255 on May 31, 2023; 198 on June 1, 2023; 225 on June 2, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025 and 225 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 125 | $227.32 | $28,415.00 |
DisclosureSEC source: 0001209191-22-034533 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,481 F1 · shares: 125 shares were withheld from the 360 restricted shares that vested on June 2, 2022. These 125 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 360 ordinary shares were awarded to Ms. Madsen on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2022. F2 · balance_after: As of June 6, 2022, 4,449 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC |
Breeden Richard CDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-22-034534 · doc4.xml · derivative · entry 3 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: This option to purchase 3,218 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,218 ordinary shares for $32.36 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,218 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,218 ordinary shares for $32.36 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC |
Breeden Richard CDirector
|
Exercise / conversionOrdinary Shares | 3,218 | $32.36 | $104,134.48 |
DisclosureSEC source: 0001209191-22-034534 · doc4.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,180 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC |
Burton Karen LVP, Controller & CAO
|
Tax withholdingOrdinary Shares | 88 | $227.32 | $20,004.16 |
DisclosureSEC source: 0001209191-22-034532 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,067 F1 · shares: 88 shares were withheld from the 196 restricted shares that vested on June 2, 2022. These 88 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 196 ordinary shares were awarded to Ms. Burton on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2022. F2 · balance_after: As of June 6, 2022, 2,483 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 86 on October 3, 2022; 255 on May 31, 2023; 198 on June 1, 2023; 225 on June 2, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025 and 225 on June 2, 2026. Read SEC document |
| June 02, 2022 Filed Jun 6, 2022 20:35 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 368 | $227.32 | $83,653.76 |
DisclosureSEC source: 0001209191-22-034531 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,595 F1 · shares: 368 shares were withheld from the 819 restricted shares that vested on June 2, 2022. These 368 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 819 ordinary shares were awarded to Mr. Zangerle on June 2, 2021. These vested shares were valued at the NYSE closing market price on June 2, 2022. F2 · balance_after: As of June 6, 2022, 8,987 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:58 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 42 | $221.46 | $9,301.32 |
DisclosureSEC source: 0001209191-22-034157 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,198 F1 · shares: 42 shares were withheld from the 123 restricted shares that vested on June 1, 2022. These 42 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 123 ordinary shares were awarded to Ms. Madsen on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. F2 · balance_after: As of June 2, 2022, 4,809 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 352 on June 2, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 352 on June 3, 2024; 123 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 352 on June 2, 2025; 360 on June 2, 2025; 144 on October 1, 2025 and 352 on June 2, 2026. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:56 UTC |
Fraser Mary ClareSVP & Chief HRO
|
Tax withholdingOrdinary Shares | 235 | $221.46 | $52,043.10 |
DisclosureSEC source: 0001209191-22-034149 · doc4.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,223 F1 · shares: 235 shares were withheld from the 791 restricted shares that vested on June 1, 2022. These 235 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 791 ordinary shares were awarded to Ms. Fraser on August 4, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. F2 · balance_after: As of June 2, 2022, 6,138 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 791 on June 1, 2023; 791 on June 1, 2024; 1,836 on June 2, 2025; 692 on October 1, 2025 and 2,028 on June 2, 2026. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:57 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 675 | $221.46 | $149,485.50 |
DisclosureSEC source: 0001209191-22-034152 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,579 F1 · shares: 675 shares were withheld from the 1,504 restricted shares that vested on June 1, 2022. These 675 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 1,504 ordinary shares were awarded to Mr. Zangerle on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. F2 · balance_after: As of June 2, 2022, 9,806 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 846 on June 2, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 846 on June 3, 2024; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 846 on June 2, 2025; 202 on October 1, 2025 and 846 on June 2, 2026. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 20:55 UTC |
Burton Karen LVP, Controller & CAO
|
Tax withholdingOrdinary Shares | 178 | $221.46 | $39,419.88 |
DisclosureSEC source: 0001209191-22-034143 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,255 F1 · shares: 178 shares were withheld from the 396 restricted shares that vested on June 1, 2022. These 178 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 396 ordinary shares were awarded to Ms. Burton on June 1, 2020. These vested shares were valued at the NYSE closing market price on June 1, 2022. F2 · balance_after: As of June 2, 2022, 2,679 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 196 on June 2, 2022; 86 on October 3, 2022; 255 on May 31, 2023; 198 on June 1, 2023; 225 on June 2, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 225 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 225 on June 2, 2025; 196 on June 2, 2025; 86 on October 1, 2025 and 225 on June 2, 2026. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:04 UTC |
Madsen JuliaSenior VP, Life Sciences
|
Tax withholdingOrdinary Shares | 72 | $228.20 | $16,430.40 |
DisclosureSEC source: 0001209191-22-033701 · doc4.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Senior VP, Life Sciences 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,240 F1 · shares: 72 shares were withheld from the 213 restricted shares that vested on May 31, 2022. These 72 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 213 ordinary shares were awarded to Ms. Madsen on May 31, 2018 and May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 3,524 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 123 on June 1, 2022; 360 on June 2, 2022; 349 on October 3, 2022; 144 on October 3, 2022; 92 on May 31, 2023; 123 on June 1, 2023; 360 on June 2, 2023; 349 on October 2, 2023; 144 on October 2, 2023; 23 on June 3, 2024; 360 on June 3, 2024; 349 on October 1, 2024; 144 on October 1, 2024; 360 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:08 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 151 | $228.20 | $34,458.20 |
DisclosureSEC source: 0001209191-22-033711 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,565 F1 · shares: 151 shares were withheld from the 484 restricted shares that vested on May 31, 2022. These 151 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 484 ordinary shares were awarded to Mr. Tamaro on May 31, 2018. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 2,060 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 556 on May 31, 2023; 584 on June 3, 2024; 432 on June 3, 2024; 258 on October 1, 2024; 144 on June 2, 2025 and 86 on October 1, 2025. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:07 UTC |
Majors Cary LSr VP Americas Com Operations
|
Tax withholdingOrdinary Shares | 742 | $228.20 | $169,324.40 |
DisclosureSEC source: 0001209191-22-033707 · doc4.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · Sr VP Americas Com Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,955 F1 · shares: 742 shares were withheld from the 2,520 restricted shares that vested on May 31, 2022. These 742 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,520 ordinary shares were awarded to Mr. Majors on May 31, 2018. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 7,247 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,224 on May 31, 2023; 2,367 on June 3, 2024; 1,964 on June 2, 2025 and 692 on October 1, 2025. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:05 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 1,285 | $228.20 | $293,237.00 |
DisclosureSEC source: 0001209191-22-033703 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,159 F1 · shares: 1,285 shares were withheld from the 4,240 restricted shares that vested on May 31, 2022. These 1,285 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 4,240 ordinary shares were awarded to Mr. Tokich on May 31, 2018. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 8,100 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 22:59 UTC |
Burton Karen LVP, Controller & CAO
|
Tax withholdingOrdinary Shares | 942 | $228.20 | $214,964.40 |
DisclosureSEC source: 0001209191-22-033692 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,433 F1 · shares: 942 shares were withheld from the 2,097 restricted shares that vested on May 31, 2022. These 942 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,097 ordinary shares were awarded to Ms. Burton on May 31, 2018 and May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 2,175 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 396 on June 1, 2022; 196 on June 2, 2022; 86 on October 3, 2022; 255 on May 31, 2023; 198 on June 1, 2023; 196 on June 2, 2023; 86 on October 2, 2023; 198 on June 3, 2024; 196 on June 3, 2024; 86 on October 1, 2024; 196 on June 2, 2025 and 86 on October 1, 2025. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:00 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 810 | $228.20 | $184,842.00 |
DisclosureSEC source: 0001209191-22-033695 · doc4.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,039 F1 · shares: 810 shares were withheld from the 2,712 restricted shares that vested on May 31, 2022. These 810 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 2,712 ordinary shares were awarded to Mr. Carestio on May 31, 2018. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 18,400 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,748 on October 3, 2022; 289 on October 3, 2022; 5,008 on May 31, 2023; 3,324 on June 1, 2023; 3,028 on June 2, 2023; 289 on October 2, 2023; 1,108 on June 3, 2024; 1,514 on June 3, 2024; 289 on October 1, 2024; 1,514 on June 2, 2025 and 289 on October 1, 2025. Read SEC document |
| May 31, 2022 Filed Jun 2, 2022 23:02 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 2,769 | $228.20 | $631,885.80 |
DisclosureSEC source: 0001209191-22-033698 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,254 F1 · shares: 2,769 shares were withheld from the 6,138 restricted shares that vested on May 31, 2022. These 2,769 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 6,138 ordinary shares were awarded to Mr. Zangerle on May 31, 2018 and May 31, 2019. These vested shares were valued at the NYSE closing market price on May 31, 2022. F2 · balance_after: 7,926 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:30 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $67.98 | $0.00 |
DisclosureSEC source: 0001209191-22-025176 · doc4.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F4 · derivative.exercise_date: This option to purchase 8,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 8,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:30 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
SaleOrdinary Shares | 8,000 | $255.48 | $2,043,876.00 |
DisclosureSEC source: 0001209191-22-025176 · doc4.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,023 F1 · shares: This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $255.48 to $255.54 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F2 · balance_after: 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,138 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| April 20, 2022 Filed Apr 21, 2022 20:30 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Exercise / conversionOrdinary Shares | 8,000 | $67.98 | $543,840.00 |
DisclosureSEC source: 0001209191-22-025176 · doc4.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,023 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. F2 · balance_after: 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,138 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. Read SEC document |
| April 07, 2022 Filed Apr 8, 2022 21:00 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 8,000 | $250.00 | $2,000,000.00 |
DisclosureSEC source: 0001209191-22-023866 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,444 F1 · shares: This sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2021. F2 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 22:07 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-22-021838 · doc4.xml · derivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,000 shares Expires 2027-05-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 4,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 4,000 Old STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 22:07 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 4,000 | $246.00 | $984,000.00 |
DisclosureSEC source: 0001209191-22-021838 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,375 F1 · shares: This exercise of stock options and sale of a total of 4,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 18, 2022. Read SEC document |
| March 29, 2022 Filed Mar 31, 2022 22:07 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionOrdinary Shares | 4,000 | $77.07 | $308,280.00 |
DisclosureSEC source: 0001209191-22-021838 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,375 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,600 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-22-010842 · doc4.xml · derivative · entry 3 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,600 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 2,600 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 2,600 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burton Karen LVP, Controller & CAO
|
SaleOrdinary Shares | 2,600 | $232.61 | $604,786.00 |
DisclosureSEC source: 0001209191-22-010842 · doc4.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,375 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $232.5000 to $232.6650 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 22:01 UTC |
Burton Karen LVP, Controller & CAO
|
Exercise / conversionOrdinary Shares | 2,600 | $69.72 | $181,272.00 |
DisclosureSEC source: 0001209191-22-010842 · doc4.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · VP, Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 23:38 UTC |
KOSECOFF JACQUELINE BDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,218 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001209191-22-009475 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 23:38 UTC |
KOSECOFF JACQUELINE BDirector
|
SaleOrdinary Shares | 3,218 | $235.20 | $756,873.60 |
DisclosureSEC source: 0001209191-22-009475 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $235.1050 to $235.3850 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 23:38 UTC |
KOSECOFF JACQUELINE BDirector
|
Exercise / conversionOrdinary Shares | 3,218 | $32.36 | $104,134.48 |
DisclosureSEC source: 0001209191-22-009475 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:02 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 1,891 | $0.00 Strike: $71.40 | $0.00 |
DisclosureSEC source: 0001209191-22-009392 · doc4.xml · derivative · entry 3 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,891 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option is part of an option to purchase 3,781 STERIS ordinary shares, which are fully vested, which was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:02 UTC |
FELDMANN CYNTHIA LDirector
|
SaleOrdinary Shares | 1,891 | $234.10 | $442,683.10 |
DisclosureSEC source: 0001209191-22-009392 · doc4.xml · nonDerivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 705 Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 22:02 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionOrdinary Shares | 1,891 | $71.40 | $135,017.40 |
DisclosureSEC source: 0001209191-22-009392 · doc4.xml · nonDerivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:32 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001209191-21-071260 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 30,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option to purchase 30,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 30,000 Old STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. Read SEC document |
| December 23, 2021 Filed Dec 27, 2021 21:32 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
SaleOrdinary Shares | 30,000 | $240.00 | $7,200,000.00 |
DisclosureSEC source: 0001209191-21-071260 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,444 F2 · shares: This exercise of stock options and sale of a total of 30,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on June 4, 2021. F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $240.00 to $240.04 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: 12,340 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,240 on May 31, 2022; 2,780 on May 31, 2023; 2,452 on June 3, 2024; 1,719 on June 3, 2024; 432 on October 1, 2024; 573 on June 2, 2025 and 144 on October 1, 2025. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.